dimarts, 6 de maig del 2014

Biosensors lands FDA OK to launch U.S. trial of drug-eluting stent




Biosensors International prepares to launch a U.S. clinical trial of its BioFreedom drug-coated stent, which is already available in Europe.





Biosensors lands FDA OK to launch U.S. trial of drug-eluting stent

Biosensors International Group Ltd., Food & Drug Administration (FDA)

News Well, Clinical Trials, Investigational Device Exemption (IDE), Regulatory/Clearance, Drug-Eluting Stents, Food & Drug Administration (FDA), Stents

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1myw7k6
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)